Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (185)

Search Parameters:
Authors = Angela Russo ORCID = 0000-0002-7322-4190

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
10 pages, 390 KiB  
Article
Art Therapy and Its Impact on Mood and Emotional States in Pediatric Hematology Oncology Units: Translation and Validation of the Italian Version of the Arts Observational Scale (ArtsObS)
by Marianna Avola, Enrica Garibaldi, Milena La Spina, Andrea Di Cataldo, Giovanna Russo, Luca Lo Nigro, Maria Montanaro, Dorella Scarponi, Angela Militello, Clara Raciti, Federica Maio, Antonella Agodi, Martina Barchitta, Paola Adamo, Soani Duca, Davide Massidda, Momcilo Jankovic, Giulia Zucchetti and Cinzia Favara Scacco
Healthcare 2025, 13(15), 1851; https://doi.org/10.3390/healthcare13151851 - 29 Jul 2025
Viewed by 271
Abstract
Background/Objectives: Art therapy is a psychotherapeutic technique that involves the creation of tangible visual arts and represents a coping strategy to support children with cancer. Evaluating the effects of such activities on children with cancer is essential for providing evidence of the [...] Read more.
Background/Objectives: Art therapy is a psychotherapeutic technique that involves the creation of tangible visual arts and represents a coping strategy to support children with cancer. Evaluating the effects of such activities on children with cancer is essential for providing evidence of the value that creativity holds within healthcare systems. A dedicated tool for assessing the creative process is the Arts Observational Scale (ArtsObS), focusing on mood and emotional states as key indicators of psychosocial well-being. This study aims to validate a translated version of the ArtsObS in the Italian language. Methods: The translation process followed recommendations for translation and cultural adaptation. The distribution properties of the scores, internal consistency, sensitivity to change, reliability, and convergent validity were assessed through observations conducted by two different evaluators. Results: The ArtsObS in its Italian adaptation is proven to be an adequate tool for capturing changes following an intervention, with good internal consistency and low sensitivity to differences between operators. The analysis supports the reliability of the ArtsObS across different observers. Conclusions: The Italian ArtsObS is a valid and reliable instrument for evaluating the impact of art therapy on pediatric patients’ mood and emotional states. It provides a standardized tool for clinical and research settings to assess creative interventions in pediatric oncology. Full article
Show Figures

Figure 1

18 pages, 482 KiB  
Article
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Evaluation of Sequencing, Response, and Toxicity in a Single-Institution Cohort
by Maria Cristina Barba, Paola De Franco, Donatella Russo, Elisa Cavalera, Elisa Ciurlia, Sara De Matteis, Giuseppe Di Paola, Corradino Federico, Angela Leone, Antonella Papaleo, Bianca Santo, Dino Rubini, Giuseppe Rubini and Angela Sardaro
Cancers 2025, 17(15), 2416; https://doi.org/10.3390/cancers17152416 - 22 Jul 2025
Viewed by 320
Abstract
Background: Total neoadjuvant therapy (TNT) has emerged as a promising strategy for locally advanced rectal cancer (LARC). By administering both chemoradiotherapy (CRT) and systemic chemotherapy (CHT) pre-surgery, TNT is associated with improved disease-free survival (DFS), reduced distant metastases, and higher pathological complete [...] Read more.
Background: Total neoadjuvant therapy (TNT) has emerged as a promising strategy for locally advanced rectal cancer (LARC). By administering both chemoradiotherapy (CRT) and systemic chemotherapy (CHT) pre-surgery, TNT is associated with improved disease-free survival (DFS), reduced distant metastases, and higher pathological complete response (pCR) rates. Materials and Methods: This study included patients with LARC who received various TNT schedules: induction chemotherapy (iCHT), consolidation chemotherapy (cCHT), or a combination of both (sandwichCHT). We analyzed treatment adherence, toxicity, and pathological response. Local and distant disease recurrence, as well as survival outcomes, were also evaluated. Results: Between May 2021 and January 2025, 70 patients received TNT. Treatment included iCHT (41%), sandwichCHT (49%), and cCHT (10%). Most patients (94%) received long-course radiotherapy (LCRT). Overall, TNT was well tolerated, with grade 2 gastrointestinal toxicity during CRT being the most common frequent adverse event (33%). Disease progression during TNT was noted in five patients (7%); three of these patients were receiving chemotherapy, while two underwent surgical resection of the primary tumor. A watch-and-wait strategy was adopted for five patients (7%) following TNT. Surgical procedures performed included anterior resection (92%), abdominoperineal resection (7%), and local excision (1%). Pathological assessment revealed an overall pCR rate of 30%. With a median follow-up of 17 months, no patients experienced local recurrence. Post-surgery, 10 patients (17%) developed disease progression. The median DFS was 14.7 months. Five patients (7%) died during the follow-up period, with only one death attributed to causes other than disease progression. Conclusions: In this cohort of LARC patients, TNT demonstrated favorable tolerability and encouraging short-term efficacy. Full article
(This article belongs to the Section Cancer Pathophysiology)
Show Figures

Figure 1

11 pages, 1481 KiB  
Article
Efficacy and Safety Analysis of Nab-Paclitaxel Treatment in Elderly Patients with HER-2 Negative Metastatic Breast Cancer: NEREIDE Study
by Giuseppina Rosaria Rita Ricciardi, Alessandro Russo, Maria Vita Sanò, Angela Prestifilippo, Antonio Russo, Vittorio Gebbia, Livio Blasi, Dario Giuffrida, Giuseppa Scandurra, Antonio Savarino, Alfredo Butera, Nicolò Borsellino, Francesco Verderame, Michele Caruso and Vincenzo Adamo
Cancers 2025, 17(13), 2069; https://doi.org/10.3390/cancers17132069 - 20 Jun 2025
Viewed by 512
Abstract
Background: Older women represent a significant and increasing population of patients with breast cancer, accounting for over 40% of new cases of breast cancer. However, this growing subgroup of patients is still underrepresented in clinical trials, and treatment is usually selected based [...] Read more.
Background: Older women represent a significant and increasing population of patients with breast cancer, accounting for over 40% of new cases of breast cancer. However, this growing subgroup of patients is still underrepresented in clinical trials, and treatment is usually selected based on limited data from retrospective subgroup analyses. However, the ESMO guidelines for metastatic breast cancer (mBC) suggest that the management decision should not be based on age alone. Nab-paclitaxel (nab-P) was associated with improved efficacy and a better safety profile than solvent-based taxanes without steroid or antihistamine premedication, making this treatment appealing to elderly patients. Patients and methods: This is an observational, retrospective, multicenter study, evaluating the safety and activity of nab-paclitaxel (nab-P) in elderly patients (≥65 years old) with HER2-negative mBC from 11 Sicilian oncology centers. The primary endpoint of the study was the safety nab-P in elderly mBC patients; secondary endpoints included the overall response rate (ORR), progression-free survival (PFS), and overall survival (OS). Results: We included 70 patients, and all were evaluable for safety and efficacy. All patients had previously been pretreated with taxane-based chemotherapy in a (neo)-adjuvant or metastatic setting. One third of the patients received nab-P as a fourth line therapy. Most of the patients were treated with nab-P at doses of 260 mg/m2 3-weekly (87.1%), and 12.9% received a nab-P dose of 125 mg/m2 weekly. Patients’ characteristics included a median age of 67 years (range 65–83 years), a median ECOG PS of 1 (range 0–2), and the following intrinsic molecular subtypes: Luminal A (18.8%), Luminal B HER-2 negative (62.5%), and triple negative (18.8%). Nab-P was administered for a median of six cycles (range 1–21), with 35.5% of patients experiencing a dose reduction, and 11.5% treatment discontinuation due to toxicity. Adverse events were mainly G2-G3 and occurred mostly in patients treated with 3-weekly nab-P (85.7%). The ORR was 31.3% (CR in 6.3% and PR in 25% of pts) and the DCR was 70.4%. Median PFS was 6 months (95% CI, 2–38), and median OS was 40.5 months (95% CI, 7–255). Conclusions: Our real-life study showed that nab-P is an effective, well-tolerated regimen in elderly mBC patients, including taxane-pretreated patients, and can be safely administered in elderly mBC patients. Full article
(This article belongs to the Special Issue Molecular Pathology and Human Cancers)
Show Figures

Figure 1

19 pages, 3638 KiB  
Article
Bergamot and Olive Extracts as Beer Ingredients: Impact on Cell Viability, Reactive Oxygen Species, and RNA Expression of Antioxidant Enzymes
by Maria Laura Matrella, Bruna Amenta, Francesco Canino, Angela Maffia, Tiziana Cocco, Mariateresa Russo and Adele Muscolo
Foods 2025, 14(12), 2012; https://doi.org/10.3390/foods14122012 - 6 Jun 2025
Viewed by 525
Abstract
This study explores the incorporation of bergamot juice and olive extract as functional ingredients in craft beer and their effects on antioxidant activity and cellular oxidative stress. Lyophilized beer samples were applied to human fibroblast cells at concentrations of 0.31 and 0.62 µg/µL [...] Read more.
This study explores the incorporation of bergamot juice and olive extract as functional ingredients in craft beer and their effects on antioxidant activity and cellular oxidative stress. Lyophilized beer samples were applied to human fibroblast cells at concentrations of 0.31 and 0.62 µg/µL for 24 and 48 h. Cell viability, reactive oxygen species (ROS) levels, and antioxidant gene expression were evaluated. Beers enriched with bergamot (Heraclea) and olive extract (Elais) significantly reduced ROS levels compared to base beers (Blanche and Weiss), particularly at lower concentrations and shorter exposure times. However, prolonged treatment showed variable effects, suggesting possible concentration- and time-dependent pro-oxidant behavior. Gene expression analysis revealed the upregulation of the antioxidant enzyme SOD2 in all samples except Elais under oxidative stress, indicating differential cellular responses. These findings suggest that functional beers enriched with plant extracts may offer antioxidant benefits and support cellular defense mechanisms, representing a promising direction in wellness-oriented brewing. Full article
(This article belongs to the Special Issue Health Benefits of Bioactive Compounds from Vegetable Sources)
Show Figures

Figure 1

19 pages, 3901 KiB  
Article
Clinical Application of Next-Generation Sequencing for Molecular Classification in the Management of Endometrial Cancer: An Observational Cohort Study
by Sabrina Paratore, Angela Russo, Giusi Blanco, Katia Lanzafame, Eliana Giurato, Giovanni Bartoloni, Marco D’Asta, Mirella Sapienza, Valeria Solarino, Valentina Vinci, Giulia Maria Bonanno, Giuseppe Ettore and Roberto Bordonaro
Cancers 2025, 17(11), 1806; https://doi.org/10.3390/cancers17111806 - 28 May 2025
Viewed by 845
Abstract
Background/Objectives: Endometrial cancer (EC) is the most common malignancy of the female genital tract. In 2013, The Cancer Genome Atlas analyzed the molecular profile of endometrial tumors identifying four risk classes (POLE ultramutated, mismatch repair-deficient, copy-number low-microsatellite stable, and copy-number high-serous-like. This classification [...] Read more.
Background/Objectives: Endometrial cancer (EC) is the most common malignancy of the female genital tract. In 2013, The Cancer Genome Atlas analyzed the molecular profile of endometrial tumors identifying four risk classes (POLE ultramutated, mismatch repair-deficient, copy-number low-microsatellite stable, and copy-number high-serous-like. This classification is reshaping the current understanding of EC, enabling more refined risk stratification and uncovering potential therapeutic targets tailored to specific molecular subgroups. In the context of these four categories, it is possible to identify different molecular alterations that correlate with different prognoses. Methods and Results: We retrospectively analyzed tissue samples from eighty-five EC patients, performing multigene profiling using a 50-gene next-generation sequencing (NGS) panel to categorize them into distinct molecular subtypes; we observed the following distribution: 5.9% POLE, 25.8% mismatch repair-deficient/microsatellite instability (MMRd/MSI), 11.8% p53abn/TP53mut, and 56.5% NSMP. A favorable concordance (97.6%) was shown in MSI NGS-based analysis and MMR IHC results, and the agreement rate of p53 IHC and TP53 mutation was 92.3%. When we analyzed the correlation between molecular subtypes and clinicopathological features, we found that molecular subtypes significantly differentiated by grade, FIGO stage, and lymphovascular invasion (LVSI). These findings seem to support the effectiveness of our NGS-based classifier and its reliability in distinguishing both MSI and TP53 mutated cancers. This study also explored mutations in PIK3CA, PTEN, KRAS, ERBB2, and ESR1 genes, noting their potential as targets for treatments. PIK3CA mutations were linked to favorable features, such as early disease stage and absence of LVSI. Conclusions: Our study highlights the potential of a medium-complexity NGS panel for supporting the molecular classification of endometrial cancer, complementing the existing diagnostic algorithms. By identifying additional biomarkers, we provided valuable insights into the genomic landscape of EC. However, further exploration of the molecular profiles is needed to validate these findings and improve the identification of patients at a higher risk of unfavorable outcomes. Full article
Show Figures

Figure 1

9 pages, 541 KiB  
Article
Dapagliflozin’s Effects on Urinary Albumin and Non-Albumin Proteins in Diabetic and Non-Diabetic Kidney Transplant Recipients
by Giancarlo Bilancio, Sarah Hamzeh, Nicoletta Vecchione, Dora Russo, Candida Iacuzzo, Luca Apicella, Renata Angela Di Pietro, Piercarla Vitale, Maria Amicone, Antonio Pisani, Massimo Cirillo and Carmine Secondulfo
Biomedicines 2025, 13(6), 1303; https://doi.org/10.3390/biomedicines13061303 - 26 May 2025
Viewed by 542
Abstract
Background: SGLT2 inhibitors (SGLT2is) lower glucose and have renoprotective effects, including reducing proteinuria. In kidney transplant recipients (KTRs), proteinuria impacts graft and patient survival. While SGLT2is benefits have been reported in diabetic KTRs, the data on non-diabetic KTRs are poor, and no [...] Read more.
Background: SGLT2 inhibitors (SGLT2is) lower glucose and have renoprotective effects, including reducing proteinuria. In kidney transplant recipients (KTRs), proteinuria impacts graft and patient survival. While SGLT2is benefits have been reported in diabetic KTRs, the data on non-diabetic KTRs are poor, and no data are available for albuminuria and non-albumin proteinuria. This study assessed the effects of dapagliflozin on urinary protein excretion in KTRs with and without diabetes. Methods: This analysis, from the Salerno CKD Cohort Study, included 66 KTRs (≥1 year post-transplant) with proteinuria despite renin–angiotensin system inhibitor therapy. The patients received dapagliflozin (10 mg/day) for six months, with assessments at the baseline (T0), three months (T1), and six months (T2); adverse events were monitored. The primary outcomes were changes in the urinary total, albumin, and non-albumin proteins. The secondary outcomes included weight, blood pressure, and eGFR. Results: At T1, the urinary total, albumin, and non-albumin proteins were significantly decreased, with a greater reduction in the non-albumin proteins vs. albumin (−27% vs. −9.4%, p = 0.001). No further changes occurred at T2. The patients’ weight and blood pressure also declined, while their eGFR and glucose remained stable. The non-albumin protein reduction was correlated with weight loss and diastolic blood pressure changes. Two patients discontinued use due to adverse events (one with a urinary tract infection, one with hypotension). Conclusions: Dapagliflozin reduces proteinuria, particularly non-albumin proteins, in KTRs with and without diabetes, with a low incidence of adverse effects. Further studies are needed to confirm the long-term benefits, especially in non-diabetic recipients. Full article
Show Figures

Graphical abstract

12 pages, 784 KiB  
Article
The Efficacy of the RME II System Compared with the Sander Bite-Jumping Appliance: A Retrospective Study
by Mauro Lorusso, Michele Tepedino, Donatella Ferrara, Angela Pia Cazzolla, Fariba Esperouz, Rosa Esposito, Lucio Lo Russo and Domenico Ciavarella
J. Clin. Med. 2025, 14(11), 3700; https://doi.org/10.3390/jcm14113700 - 25 May 2025
Viewed by 424
Abstract
Objective: This paper aimed to assess the effectiveness of the Rapid Maxillary Expander (RME) II System, compared to the Sander bite-jumping appliance (SBJ) and an untreated control group, in the treatment of Class II skeletal malocclusion in children. Methods: Thirty Class II patients [...] Read more.
Objective: This paper aimed to assess the effectiveness of the Rapid Maxillary Expander (RME) II System, compared to the Sander bite-jumping appliance (SBJ) and an untreated control group, in the treatment of Class II skeletal malocclusion in children. Methods: Thirty Class II patients treated with the RME II System (Group R) were compared to 30 patients treated with the SBJ (Group S) and 30 untreated Class II children (Group C). Cephalograms were analysed at the beginning of the study (T0) and at the end of the treatment (T1). Eight cephalometric parameters were evaluated: the divergence angle (SN-MP), ANB, lower face height (LFH), CO-GN, 1 + SN, IMPA, overjet, and overbite. The Shapiro–Wilk normality test was conducted to assess the distribution of the data. A t-test was then used for pairwise comparisons of the cephalometric measurements between T0 and T1. Differences among the groups were analysed using one-way ANOVA with Tukey’s post hoc correction. Results: ANOVA revealed a statistically significant difference for all analysed variables except 1 + SN. The post hoc Tukey’s test identified the following differences: SN-MP was 2.51° greater in Group S than in Group R, LFH was 5.46 mm greater in Group C than in Group R and 3.11 mm greater in Group S than in Group R, IMPA was 4.01° greater in Group S than in Group R, and overbite was 1.96 mm lower in Group S than in Group R. Conclusions: The RME II System provides better control of mandibular plane inclination and lower incisor proclination during the correction of Class II skeletal malocclusion. Both devices are effective in correcting Class II skeletal malocclusion. Full article
(This article belongs to the Special Issue Orthodontics: Current Advances and Future Options)
Show Figures

Figure 1

13 pages, 255 KiB  
Review
Impact of Multiplex PCR on Diagnosis of Bacterial and Fungal Infections and Choice of Appropriate Antimicrobial Therapy
by Francesca Serapide, Rita Pallone, Angela Quirino, Nadia Marascio, Giorgio Settimo Barreca, Chiara Davoli, Rosaria Lionello, Giovanni Matera and Alessandro Russo
Diagnostics 2025, 15(8), 1044; https://doi.org/10.3390/diagnostics15081044 - 20 Apr 2025
Cited by 2 | Viewed by 1653
Abstract
Multiplex Polymerase Chain Reaction (PCR) has significantly impacted the field of infectious disease diagnostics, offering rapid and precise identification of bacterial and fungal pathogens. Unlike traditional culture methods, which may take days to yield results, multiplex PCR provides diagnostic insights within hours, enabling [...] Read more.
Multiplex Polymerase Chain Reaction (PCR) has significantly impacted the field of infectious disease diagnostics, offering rapid and precise identification of bacterial and fungal pathogens. Unlike traditional culture methods, which may take days to yield results, multiplex PCR provides diagnostic insights within hours, enabling faster, targeted antimicrobial therapy and reducing the delay in treating critical infections like sepsis. The technique’s high sensitivity and broad pathogen coverage make it ideal for both single and polymicrobial infections, improving outcomes across respiratory, bloodstream, and bacterial/fungal infections. However, multiplex PCR is not without challenges; initial high costs and the need for specialized training can limit its adoption, especially in low-resource settings. This review discusses the clinical advantages and limitations of multiplex PCR, highlighting its influence on diagnostic accuracy, antimicrobial stewardship, and the global fight against antimicrobial resistance (AMR). Furthermore, recent innovations in multiplex PCR, such as digital PCR and portable devices, are explored as potential tools for expanding access to rapid diagnostics worldwide. Full article
11 pages, 1094 KiB  
Article
Impact of Ablation Energy Sources on Perceived Quality of Life and Symptom in Atrial Fibrillation Patients: A Comparative Study
by Andrea Matteucci, Maurizio Russo, Marco Galeazzi, Claudio Pandozi, Michela Bonanni, Marco Valerio Mariani, Nicola Pierucci, Vincenzo Mirco La Fazia, Stefania Angela Di Fusco, Federico Nardi and Furio Colivicchi
J. Clin. Med. 2025, 14(8), 2741; https://doi.org/10.3390/jcm14082741 - 16 Apr 2025
Cited by 1 | Viewed by 694
Abstract
Background: Catheter ablation is a first-line treatment for rhythm control strategies in patients with atrial fibrillation (AF), with different energy sources available, including pulsed-field ablation (PFA), high-power short-duration radiofrequency (HPSD RF), conventional radiofrequency (RF), and cryoballoon ablation. Limited evidence exists on how [...] Read more.
Background: Catheter ablation is a first-line treatment for rhythm control strategies in patients with atrial fibrillation (AF), with different energy sources available, including pulsed-field ablation (PFA), high-power short-duration radiofrequency (HPSD RF), conventional radiofrequency (RF), and cryoballoon ablation. Limited evidence exists on how different ablation techniques affect patient-reported outcomes, such as patients’ quality of life (QoL) and perceived symptoms. This study aims to assess the impact of ablation energy sources on reported QoL and symptom perception after AF ablation. Methods: The study included 148 patients who underwent catheter ablation in different centers. Patients were divided into four groups according to the energy source used. Follow-up was conducted during the 6 months post-procedure. Patients were asked to complete a 20-item questionnaire evaluating quality of life, activity resumption, recovery process, perceived symptoms, and satisfaction. Comparative analyses were performed across energy groups, anesthesia types, and anesthetic drugs. Results: PFA patients reported the highest improvement in QoL scores compared to RF, HPSD RF, and cryoablation (p < 0.001). Activity resumption and symptom relief were significantly better in the PFA group compared to others (p < 0.001). Anesthesia type and anesthetic drug influenced QoL outcomes, with patients under general anesthesia showing higher QoL scores compared to deep sedation (p < 0.001). The energy source and anesthetic drug resulted in independent predictors of QoL improvement. Conclusions: Ablation energy source could impact patients’ perceived QoL and symptom relief after AF ablation. PFA demonstrated superior performance scores in QoL and symptom perception compared to other techniques. Anesthetic drugs also play a role in patient-reported outcomes and activity resumption. Full article
(This article belongs to the Special Issue Cardiac Ablation: Current Status and Future Perspectives)
Show Figures

Figure 1

17 pages, 1331 KiB  
Article
Unlocking the Health Secrets of Onions: Investigating the Phytochemical Power and Beneficial Properties of Different Varieties and Their Parts
by Adele Muscolo, Angela Maffia, Federica Marra, Santo Battaglia, Mariateresa Oliva, Carmelo Mallamaci and Mariateresa Russo
Molecules 2025, 30(8), 1758; https://doi.org/10.3390/molecules30081758 - 14 Apr 2025
Viewed by 1840
Abstract
Onions (Allium cepa L.) are widely consumed worldwide and are recognized for their high content of bioactive compounds with potential health benefits. This study investigates the nutritional and phytochemical properties of three onion varieties—Tropea red onion, red onion, and yellow onion—analyzed in [...] Read more.
Onions (Allium cepa L.) are widely consumed worldwide and are recognized for their high content of bioactive compounds with potential health benefits. This study investigates the nutritional and phytochemical properties of three onion varieties—Tropea red onion, red onion, and yellow onion—analyzed in their whole form as well as in their peel and pulp. An innovative drying system was employed to assess its impact on the retention of bioactive compounds. The results highlight significant differences in nutrient composition among varieties and onion parts. The peel exhibited the highest concentrations of proteins, phenolic compounds, flavonoids, and antioxidants, followed by the whole onion and pulp. Tropea red onion stood out for its superior antioxidant capacity, vitamin C content, and phenolic acid levels, reinforcing its potential for functional food applications. This study also revealed that mineral content, particularly calcium, potassium, and sulfates, varied across onion varieties, influencing their nutritional and health-promoting properties. These findings support the valorization of onion byproducts for their bioactive potential and sustainability in the food industry. The data emphasize the need for further research on innovative processing techniques that enhance the bioavailability and effectiveness of onion-derived health-promoting compounds. Full article
(This article belongs to the Special Issue Extraction and Analysis of Natural Products in Food—2nd Edition)
Show Figures

Graphical abstract

8 pages, 500 KiB  
Article
Impact of SGLT2 Inhibitors on Magnesium in Kidney Transplant Patients with and Without Diabetes
by Carmine Secondulfo, Nicoletta Vecchione, Dora Russo, Sarah Hamzeh, Candida Iacuzzo, Luca Apicella, Renata Angela Di Pietro, Antonio Pisani, Maria Amicone, Massimo Cirillo and Giancarlo Bilancio
Int. J. Mol. Sci. 2025, 26(7), 2904; https://doi.org/10.3390/ijms26072904 - 22 Mar 2025
Cited by 2 | Viewed by 991
Abstract
Magnesium (Mg2+) is essential for cardiovascular and metabolic health, yet hypomagnesemia is common in kidney transplant recipients (KTRs) due to immunosuppressive therapy and renal dysfunction. Oral Mg2+ supplementation is often ineffective due to poor absorption and side effects. Sodium-glucose cotransporter [...] Read more.
Magnesium (Mg2+) is essential for cardiovascular and metabolic health, yet hypomagnesemia is common in kidney transplant recipients (KTRs) due to immunosuppressive therapy and renal dysfunction. Oral Mg2+ supplementation is often ineffective due to poor absorption and side effects. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have been shown to increase serum Mg2+ in chronic kidney disease, but their effects in KTRs, particularly patients without diabetes, remain unclear. This observational study assessed 63 KTRs treated with dapagliflozin, analyzing the serum Mg2+ levels at baseline and after 3 and 6 months. The hypomagnesemia prevalence, associations with oral supplementation, diabetes status, and diuretic use were evaluated. The results showed a significant Mg2+ increase with SGLT2i therapy, reducing hypomagnesemia regardless of the diabetes status. Oral supplementation did not correlate with improved Mg2+ levels, reinforcing its limited efficacy. Additional benefits included reductions in the body weight, blood pressure, and serum urate without compromising graft function. SGLT2i may offer a novel approach to managing hypomagnesemia in KTRs, potentially reducing the reliance on ineffective supplements while providing renal and cardiovascular benefits. Further research is needed to confirm these findings and elucidate the underlying mechanisms. Full article
(This article belongs to the Special Issue The Role of Trace Elements in Nutrition and Health)
Show Figures

Figure 1

14 pages, 907 KiB  
Article
An Innovative Analytical Approach for Multi-Mycotoxin Detection in Craft Beer Using Freeze-Dried Samples, IAC Column and HPLC/ESI-MS/MS
by Pietro Andronaco, Rosa Di Sanzo, Francesco Ioppolo, Francesco Ligato, Simone Alberto, Maria Angela Galluccio, Sonia Carabetta and Mariateresa Russo
Foods 2025, 14(6), 956; https://doi.org/10.3390/foods14060956 - 11 Mar 2025
Viewed by 1172
Abstract
The detection and quantification of mycotoxins in beer are critical for ensuring consumer safety and regulatory compliance. These contaminants, originating from barley and other grains, persist and potentially transform during the brewing process. This study presents an innovative analytical protocol using liquid chromatography/electrospray [...] Read more.
The detection and quantification of mycotoxins in beer are critical for ensuring consumer safety and regulatory compliance. These contaminants, originating from barley and other grains, persist and potentially transform during the brewing process. This study presents an innovative analytical protocol using liquid chromatography/electrospray ionization tandem mass spectrometry (HPLC/ESI-MS/MS) for the simultaneous qualitative and quantitative analysis of nine mycotoxins, including aflatoxins (AFB1, AFB2, AFG1, AFG2), Ochratoxin A (OTA), Fumonisins (FB1, FB2), Deoxynivalenol (DON), and HT-2. The method leverages the efficiency of multi-mycotoxin immunoaffinity columns, providing streamlined sample preparation with high specificity and sensitivity. Validation was conducted using craft beers from Calabria, including freeze-dried samples to enhance analytical consistency and stability. The method’s accuracy was confirmed by using spiking samples with mycotoxins at concentrations compliant with the European Commission’s regulations (Recommendation 2024/1038/EU). The developed protocol delivers reliable results with minimized resource consumption, offering a robust tool for quality control and safety assessments in brewing. By addressing knowledge gaps in freeze-dried craft beer, this study contributes to advancing food safety standards in the brewing industry. Full article
(This article belongs to the Section Food Quality and Safety)
Show Figures

Graphical abstract

17 pages, 321 KiB  
Article
Italian Validation and Psychometric Properties of the New Work Values Scale
by Lavinia Cicero, Carlotta Catania, Adriano Russo, Andrea Zammitti, Angela Russo and Giuseppe Santisi
Eur. J. Investig. Health Psychol. Educ. 2025, 15(3), 28; https://doi.org/10.3390/ejihpe15030028 - 25 Feb 2025
Viewed by 1047
Abstract
The construction of a fulfilling career and the people management processes within organizations, like the selection of personnel, require a multidisciplinary approach that takes into account psychological, social, and cultural factors. Various concepts have been suggested to explain work motivations and organizational outcomes, [...] Read more.
The construction of a fulfilling career and the people management processes within organizations, like the selection of personnel, require a multidisciplinary approach that takes into account psychological, social, and cultural factors. Various concepts have been suggested to explain work motivations and organizational outcomes, including work values. Work values can encompass individual preferences, as well as moral standards and social norms. This broad definition has led to a variety of work value measurement instruments. One brief and cutting-edge measure that integrates different approaches is the New Work Values Scale (NWVS). The aim of this study was to validate the Italian form of this measure (NWVS-I). A sample of 397 Italian adults from 19 to 66 years of age (M = 30.78, SD = 13.38) participated in the study and completed both the New Work Values Scale—Italian form (NWVS-I) and the Portraits Value Questionnaire (PVQ). First, we evaluated the structure of the New Work Values Scale—Italian form (NWVS-I) through confirmatory factor analysis (CFA), followed by a concurrent validity analysis correlating the dimensions of the New Work Values Scale—Italian form (NWVS-I) with those assessed by the Portraits Value Questionnaire (PVQ). We also tested gender invariance. The results confirmed the factor structure of the scale and its validity in the Italian context. The New Work Values Scale—Italian form (NWVS-I) is a useful measure in understanding the work values of individuals in the Italian context. This measure can be used for a wide range of applications, contributing to promoting greater awareness of one’s values and facilitating career choices, personnel selection, and people management aligned with a vision of sustainable organizational development. Full article
18 pages, 465 KiB  
Article
Optimising Aripiprazole Long-Acting Injectable: A Comparative Study of One- and Two-Injection Start Regimens in Schizophrenia with and Without Substance Use Disorders and Relationship to Early Serum Levels
by Giada Trovini, Ginevra Lombardozzi, Georgios D. Kotzalidis, Luana Lionetto, Felicia Russo, Angela Sabatino, Elio Serra, Simone Castorina, Giorgia Civita, Sara Frezza, Donatella De Bernardini, Giuseppe Costanzi, Marika Alborghetti, Maurizio Simmaco, Ferdinando Nicoletti and Sergio De Filippis
Int. J. Mol. Sci. 2025, 26(3), 1394; https://doi.org/10.3390/ijms26031394 - 6 Feb 2025
Cited by 2 | Viewed by 3367
Abstract
Aripiprazole as a long-acting injectable (LAI) is initiated in oral aripiprazole-stabilised patients and needs, after first injection, 14 days supplementation of oral aripiprazole (one-injection start, OIS). Recently, an alternative two-injection start (TIS) was advanced, involving two 400 mg injections with a single 20 [...] Read more.
Aripiprazole as a long-acting injectable (LAI) is initiated in oral aripiprazole-stabilised patients and needs, after first injection, 14 days supplementation of oral aripiprazole (one-injection start, OIS). Recently, an alternative two-injection start (TIS) was advanced, involving two 400 mg injections with a single 20 mg oral supplementation of aripiprazole. We tested the two regimens in patients with schizophrenia (SCZ, n = 152, 90 men and 62 women) with (SUD+; n = 93) or without (SUD; n = 59) substance use disorders (SUDs), comparing OIS (n = 66) with TIS (n = 86) and SUD+ vs. SUD. For 26 patients, we measured weekly for one month, aripiprazole + dehydroaripiprazole (active moiety) levels. Patients were followed for three months after LAI with psychopathology and quality-of-life scales (BPRS, CGI-S, ACES, BIS-11, and WHOQOL). All groups improved in psychopathology with no differences between OSI and TIS and between SCZ–SUD+ and SCZ–SUD. The TIS group was associated with serum blood levels of the active moiety within the therapeutic window, while the OIS group showed peaks above the window, possibly exposing patients to toxicity. Treatments were well-tolerated. Here we showed no disadvantages for TIS vs. OIS and possibly increased safety. Shifting the initiation of aripiprazole LAIs to the TIS modality may be safe and pharmacokinetically advantageous. Full article
Show Figures

Figure 1

11 pages, 1629 KiB  
Article
Circulation of a Unique Klebsiella pneumoniae Clone, ST147 NDM-1/OXA-48, in Two Diverse Hospitals in Calabria (Italy)
by Emanuele Nicitra, Morena Terrana, Dafne Bongiorno, Saveria Dodaro, Francesca Greco, Sonia Greco, Nadia Marascio, Maria Vittoria Mauro, Marta Pantanella, Grete Francesca Privitera, Angela Quirino, Francesca Serapide, Enrico Maria Trecarichi, Valeria Vangeli, Antonio Mastroianni, Giovanni Matera, Alessandro Russo and Stefania Stefani
Antibiotics 2025, 14(2), 128; https://doi.org/10.3390/antibiotics14020128 - 26 Jan 2025
Viewed by 1943
Abstract
Background/Objectives: Carbapenem-resistant Klebsiella pneumoniae has become endemic in Europe, including in Italy, where its prevalence has risen dramatically, primarily due to epidemic clones harboring metallo-enzymes. This study aims to investigate the dissemination of K. pneumoniae strains co-producing OXA-48 and NDM-1 between two hospitals [...] Read more.
Background/Objectives: Carbapenem-resistant Klebsiella pneumoniae has become endemic in Europe, including in Italy, where its prevalence has risen dramatically, primarily due to epidemic clones harboring metallo-enzymes. This study aims to investigate the dissemination of K. pneumoniae strains co-producing OXA-48 and NDM-1 between two hospitals in southern Italy using molecular analyses. Methods: A total of 49 K. pneumoniae strains, predominantly co-producing OXA-48 and NDM-1, were collected between March and December 2023. Antibiotic susceptibility testing was conducted following EUCAST guidelines. Whole-genome sequencing (Illumina MiSeq) and bioinformatics tools (CARD, CLC Genomics Workbench) were used to identify resistance and virulence genes, capsule loci, and phylogenetic relationships. Results: All isolates exhibited multidrug-resistant or extensively drug-resistant profiles, including resistance to ceftazidime/avibactam and meropenem/vaborbactam. Genomic analysis revealed diverse resistance genes such as blaOXA-48, blaNDM-1, blaCTX-M-15, and blaSHV variants. Virulence genes associated with capsules, fimbriae, and siderophores were widespread. Most strains were classified as ST147 by MLST and contained various plasmids known to carry antimicrobial resistance. Phylogenetic analysis confirmed their clonal relatedness, highlighting the intra-hospital dissemination of high-risk clones. Conclusions: High-risk K. pneumoniae clones, particularly ST147, pose significant challenges in healthcare settings due to the extensive antimicrobial resistance driven by plasmid-borne resistance genes, including those that co-produce carbapenemases, like blaNDM-1 and blaOXA-48. Molecular monitoring of these clones is essential for improving targeted infection control strategies, mitigating the spread of multidrug-resistant pathogens, and managing their clinical impact effectively. Full article
Show Figures

Figure 1

Back to TopTop